Navigation Links
China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2011 on June 2, 2011
Date:4/27/2011

BEIJING, April 27, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the fourth fiscal quarter ("4Q FY2010") and the full fiscal year ended March 31, 2011 ("FY2010") before the U.S. market opens on June 2, 2011.

The Company will also provide outlook for the first fiscal quarter ending June 30, 2011 as well as the full fiscal year ending March 31, 2012 in the results announcement.

The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on June 2, 2011 (8:00 p.m. Beijing/Hong Kong time on June 2, 2011).

Conference CallThe dial-in details for the live conference call are as follows:- U.S. Toll Free Number 1-800-215-2410- International Dial-in Number 1-617-597-5410Passcode: CMEDCALLA live webcast of the conference call will be available on http://ir.chinameditech.com.

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m. U.S. Eastern Time on June 3, 2011.  The dial-in details for the replay are as follows:

- U.S. Toll Free Number 1-888-286-8010- International Dial-in Number 1-617-801-6888Passcode: 61583099About China Medical Technologies, Inc.China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its revenues in China through the sale of diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales personnel and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit http://www.chinameditech.com.

ContactWinnie YamTel: 852-2511-9808Email: IR@chinameditech.com
'/>"/>

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
2. China Shenghuo Announces New Chief Financial Officer
3. Tens of thousands of buyers including Coles Group, El Corte Ingles, Kingfisher, Sears, The Home Depot and Tesco registered to attend China Sourcing Fairs
4. Medical Care Technologies Inc. Signs Letter of Intent for Joint Venture in China
5. China Botanic Pharmaceutical Provides Update on Badger Oil Sales
6. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
7. Reportlinker Adds ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
8. Canton Fair: Chinas Greatest Trade Fair to Open in April
9. China Botanic Pharmaceutical Approved to Produce Water-Based Mixtures
10. C3i Opens Asia Language Center in Dalian, China
11. China Sky One Medical Obtains Production Licenses for Thirteen New Medical Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 The Board of Directors of ... General Meeting, which is to take place on Thursday, April 27, ... Lund, Sweden . ... Please see the attached notification, which is being announced ... NeuroVive Pharmaceutical AB (Publ) The Board Of Directors ...
(Date:3/22/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Respiratory care devices ... over the next decade to reach approximately $38.27 billion by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... , March 22, 2017 Ampio ... the development of Ampion™, a low molecular weight ... today announced that it is re-issuing its previous release ... incorporate certain disclosures that are required under the ... below are these additional disclosures along with the ...
Breaking Medicine Technology:
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... ... educational training program owned and organized by HMP Communications Holdings, LLC, today announced ... for physicians within its nationwide network of wound centers interested in becoming Certified ...
(Date:3/23/2017)... ... 2017 , ... After raising more than $1.135 million ($1,479,231 AUD) from nearly ... in crowdfunding history, has established a U.S. Headquarters in New York City, FaceCradle ... , “We’re excited to be operating on U.S. shores, where most of our initial ...
(Date:3/23/2017)... Grants Pass, OR (PRWEB) , ... March 23, 2017 , ... ... Power of Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on ... 22nd, but she also used the occasion to remind listeners of an important distinction. ...
(Date:3/23/2017)... , ... March 23, 2017 , ... Inflow IQ & ... is serious so build on a solid foundation. As experts in dangerous situations ... information that is coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems ...
(Date:3/23/2017)... ... March 23, 2017 , ... The founders of Dr. Wang ... winners of American Dreams & Good Housekeeping Seal Initiative, a nationwide search for ... Good Housekeeping. , Steven Wang, MD ., a renowned dermatologist and medical ...
Breaking Medicine News(10 mins):